During my doctoral studies in the Ph.D. Program in Medical Sciences at Tokyo Medical and Dental University (now Institute of Science Tokyo), I investigated the molecular mechanisms and pathological roles of the brain D-serine system, focusing particularly on its involvement in schizophrenia and its potential as a therapeutic target.

At the Department of Mental Disorder Research, National Center of Neurology and Psychiatry, I analyzed D-serine and related biomarkers in cerebrospinal fluid and plasma samples from patients with psychiatric disorders. In parallel, through clinical experience as a hospital pharmacist, I developed a practical understanding of psychiatric pharmacotherapy and conducted clinical research aimed at identifying novel biomarkers for psychiatric disorders.

After moving to the United States, I trained in basic neuroscience research at the Laboratory of Molecular and Cellular Neurobiology at the National Institutes of Mental Health.

I am currently working at the National Center of Neurology and Psychiatry, where I conduct research on the role of inflammation and NMDA receptors in the pathophysiology of PTSD, integrating both basic and clinical approaches. My goal is to contribute to a deeper understanding of psychiatric disorders and to the development of more personalized, effective treatments.